Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dalbavancin in Gram-positive periprosthetic joint infections
Sebastian Simon, Bernhard J. H. Frank, Susana Gardete, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 8, pp. 2274-2277
Closed Access | Times Cited: 17

Showing 17 citing articles:

Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel
Éric Senneville, Guillermo Cuervo, Matthieu Grégoire, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 5, pp. 106960-106960
Open Access | Times Cited: 29
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections
Dario Cattaneo, Marta Fusi, Lucia Galli, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 4
Open Access | Times Cited: 7
Dalbavancin as suppressive therapy for implant-related infections: a case series with therapeutic drug monitoring and review of the literature
B. Lafon-Desmurs, Benoît Gachet, Benjamin Hennart, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 7, pp. 1475-1480
Closed Access | Times Cited: 7
Cutibacterium avidum: A Potent and Underestimated Pathogen in Prosthetic Hip Joint Infections
Johanna Karlsson, Nina Kamenska, Erika Matuschek, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 432-432
Open Access | Times Cited: 5
High vs. low vancomycin therapeutic concentrations in periprosthetic joint infection: A retrospective cohort analysis
Jingdong Cheng, Wang De-hua, Yanqing Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Monitorización terapéutica de dalbavancina: revisión sistemática de estrategias y aplicaciones clínicas en el tratamiento de infecciones complejas
Laura Moñino-Dominguez, Alicia Aguado-Paredes, Jaime Ramos
Farmacia Hospitalaria (2025)
Open Access
An Updated Mini-Review on Adverse Effects of Second-Generation Glycopeptide Antibiotics: Telavancin, Dalbavancin and Oritavancin
Zhijie Yan, Hui Chen, Ping Zeng, et al.
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 2
Closed Access
Dalbavancin for the treatment of bone and joint infections: A meta-analysis
Thamer A. Almangour, Marwan Alrasheed
Journal of Infection and Chemotherapy (2024) Vol. 31, Iss. 1, pp. 102473-102473
Closed Access | Times Cited: 3
A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections
Dimitra Dimopoulou, Elpis Mantadakis, Christos Koutserimpas, et al.
Antibiotics (2023) Vol. 12, Iss. 10, pp. 1492-1492
Open Access | Times Cited: 8
Dalbavancin as an alternative to traditional outpatient parenteral antimicrobial therapy for deep gram-positive infections – an observational, retrospective review
Hongkai Bao, Rita Igwilo-Alaneme, Fnu Sonia, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 2
Corynebacterium striatum Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin
Bo Söderquist, Thomas Henningsson, Marc Stegger
Microorganisms (2023) Vol. 11, Iss. 3, pp. 550-550
Open Access | Times Cited: 6
Real-World Data Regarding Dalbavancin Use before and during the COVID-19 Pandemic—A Single-Center Retrospective Study
Πέτρος Ιωάννου, Nora Wolff, Anna Mathioudaki, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1205-1205
Open Access | Times Cited: 5
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience
Dario Cattaneo, Marta Fusi, Marta Colaneri, et al.
Antibiotics (2023) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 5
The pathogenicity and virulence of the opportunistic pathogen Staphylococcus epidermidis
Órla Burke, Merve S. Zeden, James P. O’Gara
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Antibiotics with antibiofilm activity – rifampicin and beyond
Luı́s Pinto Ferreira, Ema Pos, Daniela Rodrigues Nogueira, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Comment on: Dalbavancin in Gram-positive periprosthetic joint infections
Johan Courjon, Aurélien Dinh, Adrien Lemaignen, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 78, Iss. 2, pp. 561-561
Closed Access | Times Cited: 2
Dalbavancin in Gram-positive periprosthetic joint infections–authors’ response
Sebastian Simon, Bernhard J. H. Frank, Susana Gardete, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 5, pp. 1316-1316
Closed Access
Complex Outpatient Antimicrobial Therapy: Alternative Management Strategies and Outcomes
Tucker John Guy Smith, Peter T. Daniels, Barry Rittmann
Current Infectious Disease Reports (2023) Vol. 25, Iss. 12, pp. 305-312
Closed Access
Page 1

Scroll to top